{"id":1010762,"date":"2026-10-15T16:38:30","date_gmt":"2026-10-15T20:38:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/"},"modified":"2026-10-15T16:38:30","modified_gmt":"2026-10-15T20:38:30","slug":"spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/","title":{"rendered":"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>CAMBRIDGE, Mass., Oct.  15, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w2sVKY3vfqRF20UQYV19NRe5plb1RuOkAMh-2_2YcSeKn5Zkydr5PRIvxb27YMDbW8lYk2bzYTvudMewjqoCXBytBEhbPwgowHGZtuzaNN8=\" rel=\"nofollow\" target=\"_blank\">Spero Therapeutics, Inc.<\/a> (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that Esther Rajavelu, Spero&#8217;s President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10<sup>th<\/sup> Annual Healthcare Conference to be held in New York City, on October 20<sup>th<\/sup>, 2026. Spero&#8217;s leadership team will also be available for one-on-one meetings at the conference.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;vertical-align: bottom\">\n            <strong>Presentation Details<\/strong>\n          <\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%;vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Date \/ time:\u00a0<\/td>\n<td style=\"vertical-align: bottom\">October 20, 2026, 9:15 AM ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Format:\u00a0<\/td>\n<td style=\"vertical-align: bottom\">Fireside chat<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Location:<\/td>\n<td style=\"vertical-align: bottom\">Holmes II, Lotte New York Palace<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Webcast Link<\/td>\n<td style=\"vertical-align: bottom\">\n            <a href=\"https:\/\/urldefense.proofpoint.com\/v2\/url?u=https-3A__event.summitcast.com_view_nUJwqi8DxFcP2EqRxm6gQf_YBZD8boLjrAFwAQu3ZJgFB&amp;d=DwMFAg&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=Q7YLhniU96gA4zk08wZ3OJQZdafT2dWDowtNiwTrDWo&amp;m=eiFcmIjYqmYcSaYUCaWqRiiPLktDJbb3xLXQV3Xq8I7hsmapKD0I6Kq7IY9s_CbZ&amp;s=Z2xRZOMxXJUNPaLkGyC9yfHZZGb5JbkoDWo3v0keD8g&amp;e=\" rel=\"nofollow\" target=\"_blank\">Here<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>The webcast may also be accessed through Spero&#8217;s website on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=q_btDGX6LgikVl6oKGEUaeah2HOhanjnvg2jPPvGSGGxK4MEwhFRxJ9PgbW92P6e4GjTD2_W36z_9vif62nyVSNUIYrRJ32o7a84HHkE6SEd0jb_naf1Xr2b2zaM2v-h6CzGfMfaoqeFKjVgJWMxsg==\" rel=\"nofollow\" target=\"_blank\">Events + Presentations<\/a> page. A replay will be available for approximately 90 days following the conference. To request a meeting or for more details about the conference please contact your institutional representative at Chardan.<\/p>\n<p>\n        <strong>About Spero Therapeutics<\/strong>\n      <\/p>\n<p>Spero Therapeutics is a clinical-stage biopharmaceutical company focused on advancing next-generation medicines for patients with serious immune-mediated diseases. The company&#8217;s lead program, SP001, is a third-generation, Fc-silent anti-CD40L monoclonal antibody being advanced first in IgG4-related disease, with potential for development in additional immunological &amp; inflammatory diseases. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-rOf_u0slSs7k2JnAinr6g9adLqoQovBWLwkpvZd9pb4X_CypyyVvscBA6V5oATHmQU-E6S7Ml5FOLnZqTYCKw==\" rel=\"nofollow\" target=\"_blank\">www.sperotx.com<\/a>.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Shai Biran, PhD<br \/>Spero Therapeutics<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4luqIKVTiFmHbytTNj75AOWEiR1l1xhrCH6RBO9IuFF8WC2KyaN42l8OffX0VgUnejD1GZG6_53H0_NGGZeq1yrU4Pln9PzjhtwhJXXsTesTk-5LPiOGUNRseDI_2r8X\" rel=\"nofollow\" target=\"_blank\"><u>IR@Sperotherapeutics.com<\/u><\/a><\/p>\n<p>\n        <strong>Media Inquiries:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iIPCtQncY2gQRcshO75eKYcxtexLKdnvG6ljucJ2qbtWzYWelsF_f_fXpikHqoPtA4IqP_lDoNwqWUupyJZohmcCQ0h7E8g8OXPi7kuSNNOOIk1c0gfCyx4pV3L-g-MK\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>media@sperotherapeutics.com<\/u><br \/>\n        <\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWE2ZDk2OWQtODZiOS00NzU2LWIzODktM2YyMTk0YWI5ZTYxLTExMDE5MzMtMjAyNi0xMC0xNS1lbg==\/tiny\/Spero-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that Esther Rajavelu, Spero&#8217;s President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10th Annual Healthcare Conference to be held in New York City, on October 20th, 2026. Spero&#8217;s leadership team will also be available for one-on-one meetings at the conference. Presentation Details \u00a0 Date \/ time:\u00a0 October 20, 2026, 9:15 AM ET Format:\u00a0 Fireside chat Location: Holmes II, Lotte New York Palace Webcast Link Here \u00a0 \u00a0 The webcast may also be accessed through Spero&#8217;s website on the\u00a0Events + Presentations page. A replay will be available &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1010762","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that Esther Rajavelu, Spero&#8217;s President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10th Annual Healthcare Conference to be held in New York City, on October 20th, 2026. Spero&#8217;s leadership team will also be available for one-on-one meetings at the conference. Presentation Details \u00a0 Date \/ time:\u00a0 October 20, 2026, 9:15 AM ET Format:\u00a0 Fireside chat Location: Holmes II, Lotte New York Palace Webcast Link Here \u00a0 \u00a0 The webcast may also be accessed through Spero&#8217;s website on the\u00a0Events + Presentations page. A replay will be available &hellip; Continue reading &quot;Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T20:38:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference\",\"datePublished\":\"2026-10-15T20:38:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/\"},\"wordCount\":222,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/\",\"name\":\"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=\",\"datePublished\":\"2026-10-15T20:38:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) &#8212; Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that Esther Rajavelu, Spero&#8217;s President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10th Annual Healthcare Conference to be held in New York City, on October 20th, 2026. Spero&#8217;s leadership team will also be available for one-on-one meetings at the conference. Presentation Details \u00a0 Date \/ time:\u00a0 October 20, 2026, 9:15 AM ET Format:\u00a0 Fireside chat Location: Holmes II, Lotte New York Palace Webcast Link Here \u00a0 \u00a0 The webcast may also be accessed through Spero&#8217;s website on the\u00a0Events + Presentations page. A replay will be available &hellip; Continue reading \"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-15T20:38:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference","datePublished":"2026-10-15T20:38:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/"},"wordCount":222,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/","name":"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=","datePublished":"2026-10-15T20:38:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NjE2MiM3ODk2ODg0IzIwOTAzNjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-participate-in-the-chardan-10th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1010762"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010762\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1010762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1010762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1010762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}